| Date | Title | | | 09/09/10 | Abiomed Announces First Patient Supported by Impella RP in Canada| DANVERS, Mass., Sep 09, 2010 (BUSINESS WIRE) --Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough
heart support technlogies, today reported that the first patient was
successfully supported for six days by the Impella(R) Right Peripheral
(RP) at the Providence Heart + Lung Institute at St. Paul's Hospital in
Vancouver, British Columbia. This is the first use of the Impella RP.
The procedure was performed by Anson Cheung, M.D. of the P... |
|  | | 09/08/10 | Abiomed to Present at Morgan Stanley 2010 Global Healthcare Unplugged
Conference| DANVERS, Mass., Sep 08, 2010 (BUSINESS WIRE) --Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough
heart support technologies, today announced that Michael R. Minogue,
Chairman, President and Chief Executive Officer, will present at the
Morgan Stanley 2010 Global Healthcare Conference on Monday, September
13, 2010 at 3:55 p.m. ET. The conference will be held at the Grand Hyatt
Hotel in New York, NY.
ABOUT ABIOMED
Based in Danvers... |
| | | 08/04/10 | Abiomed Reports Record U.S. Impella Utilization for First Quarter of
Fiscal 2011|
595 U.S. Commercial Impella Patients During the Quarter
49 Patients Enrolled in PROTECT II Study
DANVERS, Mass., Aug 04, 2010 (BUSINESS WIRE) --Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, today reported first quarter fiscal 2011 revenue
of $22.0 million, up 11% compared to the same period of fiscal 2010.
Total commercial U.S. Impella revenue, including initial site stocking
orders an... |
| | | 07/28/10 | Abiomed First Quarter Fiscal 2011 Earnings and Conference Call
Notification| DANVERS, Mass., Jul 28, 2010 (BUSINESS WIRE) --Abiomed,
Inc. (NASDAQ: ABMD) announced today that on Wednesday, August 4,
2010, the Company will release financial results for the first quarter
of fiscal 2011. The Company will host a conference call to discuss the
results on Wednesday, August 4, 2010, at 8:00 a.m. ET. Michael R.
Minogue, Chairman, President and Chief Executive Officer and Robert L.
Bowen, Vice President and Chief Financial Officer, w... |
| | | 06/08/10 | Abiomed to Present at Jefferies 2010 Global Life Sciences Conference| DANVERS, Mass., Jun 08, 2010 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, today announced that Michael R. Minogue, Chairman,
President and Chief Executive Officer, will present at the Jefferies
2010 Global Life Sciences Conference on Thursday, June 10, 2010 at 10
a.m. ET. The conference will be held at the Grand Hyatt Hotel in New
York, NY.
ABOUT ABIOMED
Based in Danvers, Massachusetts, ... |
| | | 06/03/10 | Abiomed Announces Investor/Analyst Day in Boston on June 28| Agenda to Include Presentations on Recent USpella Updates from
Leading Physicians
DANVERS, Mass., Jun 03, 2010 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, will host an investor and analyst day on Monday,
June 28, from 9:30 a.m. to 12:30 p.m. at the Intercontinental Hotel in
Boston, featuring presentations on USpella from leading physicians.
The agenda will include an overview and Q&A with... |
| | | 05/25/10 | Abiomed Reports Updated USpella Results Presented at EuroPCR 2010| DANVERS, Mass., May 25, 2010 (BUSINESS WIRE) --Abiomed
Inc. (NASDAQ: ABMD), a leading provider of breakthrough
heart support technologies, today announced that updated clinical
data from USpella will be presented at EuroPCR 2010. USpella is a U.S.
multicenter, observational registry of Impella
2.5(R) patients.
The updated USpella results will be presented at EuroPCR during a
scientific poster session by William O'Neill, M.D., University of Miami... |
| | | 05/19/10 | Abiomed Reports Record U.S. Impella Utilization of 545 Patients, up
109%|
Cash Positive During Fourth Quarter Fiscal 2010
Record Fourth Quarter Fiscal 2010 Revenue of $23.0 Million
DANVERS, Mass., May 19, 2010 (BUSINESS WIRE) --Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, today reported fourth quarter fiscal 2010 revenue
of $23.0 million, up 17% compared to revenue of $19.6 million for the
same period of fiscal 2009.
Worldwide Impella revenue for the full fis... |
| | | 05/10/10 | Abiomed Fourth Quarter and Full Year Fiscal 2010 Earnings and
Conference Call Notification| DANVERS, Mass., May 10, 2010 (BUSINESS WIRE) --Abiomed,
Inc. (NASDAQ: ABMD) announced today that on Wednesday, May 19, 2010,
the Company will release financial results for the fourth quarter and
full year of fiscal 2010. The Company will host a conference call to
discuss the results on Wednesday, May 19, 2010, at 8:00 a.m. ET. Michael
R. Minogue, Chairman, President and Chief Executive Officer and Robert
L. Bowen, Vice President and Chief Financial... |
| | | 05/07/10 | Abiomed to Present at Bank of America Merrill Lynch 2010 Healthcare
Conference| DANVERS, Mass., May 07, 2010 (BUSINESS WIRE) --Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, today announced that Michael R. Minogue, Chairman,
President and Chief Executive Officer, will present at the Bank of
America Merrill Lynch 2010 Healthcare Conference on Tuesday, May 11,
2010 at 10 a.m. ET. The conference will be held at the Grand Hyatt Hotel
in New York, NY.
ABOUT ABIOMED
Based in Danvers, Massach... |
| | | 02/04/10 | Abiomed Reports Third Quarter Fiscal 2010 Financial Results| U.S. Commercial Impella Revenue of $14.5 Million, Up 116%DANVERS, Mass., Feb 04, 2010 (BUSINESS WIRE) -- Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies, today reported third quarter fiscal 2010 revenue
of $22.8 million, up 32% compared to revenue of $17.3 million for the
same period of fiscal 2009.
Financial and operating highlights during the third quarter of fiscal
2010 include:
U.S. co... |
| | | 01/28/10 | Abiomed Third Fiscal Quarter 2010 Earnings and Conference Call
Notification| DANVERS, Mass., Jan 28, 2010 (BUSINESS WIRE) -- Abiomed,
Inc. (NASDAQ: ABMD) announced today that on Thursday, February 4,
2010, the Company will release financial results for the third quarter
of fiscal 2010. The Company will host a conference call to discuss the
results on Thursday, February 4, 2010, at 8:00 a.m. ET. Michael R.
Minogue, Chairman, President and Chief Executive Officer and Robert L.
Bowen, Vice President and Chief Financial Officer... |
| | | 01/27/10 | Abiomed Announces Partnership with Opsens to Utilize Sensor
Technology for Impella| DANVERS, Mass., Jan 27, 2010 (BUSINESS WIRE) -- Abiomed,
Inc. (NASDAQ: ABMD) ("Abiomed"), a leading provider of breakthrough
heart support technologies designed for heart recovery, today announced
a strategic partnership with Opsens (TSX VENTURE EXCHANGE: OPS)
("Opsens"), a leading developer of fiber optic sensors. Through this
partnership, Opsens' breakthrough sensor technology will be integrated
into the Impella(R) catheter to provide robust bloo... |
| | | 01/25/10 | Impella 2.5 Patient Procedure at Mount Sinai Medical Center Featuring New Product Enhancements:Webcast Available| DANVERS, Mass., Jan 25, 2010 (BUSINESS WIRE) -- Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced the webcast of a Impella(R) 2.5 procedure featuring new product enhancements at Mount Sinai Medical Center. The webcast is now available and archived on the Abiomed website (www.abiomed.com).
The webcast was broadcasted live from Mount Sinai Medical Center on January 19, 2010 and presents a successful high-risk percutaneous coronary interv... |
| | | 01/07/10 | Abiomed Announces Preliminary Record Revenue of $22.8 Million for
Third Quarter of Fiscal 2010| U.S. Commercial Impella Revenue of Approximately $14.5 Million, Up 116% From Prior YearDANVERS, Mass., Jan 07, 2010 (BUSINESS WIRE) -- Abiomed,
Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart
support technologies designed for heart recovery, today announced
preliminary third quarter fiscal 2010 revenue of approximately $22.8
million, up 32% compared to revenue of $17.3 million for the same period
of fiscal 2009. The Company will release compl... |
| | | 01/06/10 | Abiomed to Present at JP Morgan 28th Annual
Healthcare Conference in San Francisco| DANVERS, Mass., Jan 06, 2010 (BUSINESS WIRE) -- Abiomed,
Inc. (NASDAQ: ABMD) today announced that Michael R. Minogue,
Chairman, President and Chief Executive Officer, will present at the 28th
Annual JP Morgan Healthcare Conference on Wednesday, January 13, 2010 at
4:30 p.m. PT/ 7:30 p.m. ET. The conference will be held at the Westin
St. Francis from January 11 - 14, in San Francisco, California.
A live audio webcast of the presentation will be available t... |
| |
|
